Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating deferred revenue schedules or dissecting multi-year managed-services contracts in Amdocs’ SEC filings can feel overwhelming. Each 10-K spans hundreds of pages, and even a single 10-Q hides critical data on cloud migration costs deep in the footnotes. Stock Titan’s AI reads those details in seconds, translating telecom-specific jargon into plain language so you can focus on decisions, not document hunting.
Need the latest numbers? Our platform streams every Amdocs quarterly earnings report 10-Q filing the moment it hits EDGAR, alongside easy-to-scan AI summaries of segment margins, backlog trends and cash-flow drivers. Material changes are flagged instantly through 8-K material events explained in everyday terms. Curious about leadership moves? Track Amdocs insider trading Form 4 transactions with real-time alerts, or review historical Amdocs executive stock transactions Form 4 to spot buying and selling patterns.
Whether you’re benchmarking R&D intensity, checking how the company recognizes revenue under long-term arrangements, or validating compensation shifts in the proxy statement executive compensation section, our tools remove the guesswork. Key features include:
- AI-powered summaries that explain Amdocs annual report 10-K simplified
- Form-level comparisons across years for faster trend analysis
- Instant access to Amdocs Form 4 insider transactions real-time
Understanding Amdocs SEC documents with AI means you spend minutes—not hours—extracting insights that matter: segment profitability, contract backlog, and cloud transition progress. Every filing type, one intuitive dashboard.
Amdocs Limited (DOX) Form 144 notice: The filing reports a proposed sale of 2,285 shares of Common Stock through Citigroup Global Markets, Inc. (broker address provided) on 09/02/2025. The aggregate market value of the shares to be sold is listed as $195,367.50 and the total number of shares outstanding is reported as 110,000,000. The securities were acquired on 09/02/2025 by a stock option exercise and sale from AMDOCS LIMITED, and the stated nature of payment is compensation. The filer affirms, by signature, that they are not aware of any undisclosed material adverse information about the issuer.
Amdocs Limited discloses selected note items from its consolidated financial statements. Accumulated other comprehensive income (loss) components as of June 30, 2025 and 2024 include an unrealized gain on derivatives, net of tax, of $33,285 (2025) versus $587 (2024); an unrealized loss on short-term interest-bearing investments, net of tax, of $(1,739) (2025) versus $(8,805) (2024); and an unrealized loss on defined benefit plan, net of tax, of $(2,209) (2025) versus $(2,392) (2024). The company reports net-of-tax amounts of $2,485 and $622 for the three months ended June 30, 2025 and 2024, respectively, and $2,295 and $1,844 for the nine months ended June 30, 2025 and 2024, respectively. Available-for-sale securities classification changed between periods: as of June 30, 2025, $75,154 were short-term interest-bearing investments and $20,230 were cash and cash equivalents; as of September 30, 2024, $168,242 were short-term interest-bearing investments and $142,920 were cash and cash equivalents. The company references new accounting guidance on expense disaggregation effective for fiscal 2028 (annual) and 2029 (interim) and is evaluating its impact. It notes distributions of earnings to noncontrolling interests starting fiscal 2023 and discloses share repurchase authorizations totaling $2.1 billion (adopted Aug 2, 2023 and May 7, 2025) with an aggregate unused authorization of $1.12 billion. Certain items (foreign tax detail) are referenced but not specified in the excerpt.
Janus Henderson Group plc reports beneficial ownership of 5,795,194 ordinary shares of Amdocs Limited, representing 5.2% of the class. The filing shows shared voting and shared dispositive power for that stake, and no sole voting or dispositive power. An indirect subsidiary (JHIUS) is identified as a deemed beneficial owner of 5,794,432 shares and the filing states certain indirect subsidiaries are registered investment advisers providing advice to Managed Portfolios. The filing certifies these holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
FAQ
What is the current stock price of Amdocs (DOX)?
What is the market cap of Amdocs (DOX)?
